CNR1 抗体 (AA 161-187)
(4 references)Quick Overview for CNR1 抗体 (AA 161-187) (ABIN1881140)
抗原
See all CNR1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 161-187
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This CB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 161-187 amino acids of human CB1.
-
亚型
- IgG
-
-
anti-Cannabinoid Receptor 1 (CNR1) (C-Term) antibody
CNR1 适用: 人 WB, ICC, IF, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (Internal Region) antibodyVerified CNR1 适用: 人 WB, ELISA 宿主: 山羊 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (AA 73-122) antibodyCNR1 适用: 人, 大鼠, 猴, Cow, 豚鼠, Pig WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (C-Term) antibodyCNR1 适用: 人, 大鼠, 小鼠, 猴, 犬, Cow, 马, Bat, Pig IHC, ICC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) antibodyMicroarray verified CNR1 适用: 人, 小鼠 IHC 宿主: 小鼠 Monoclonal MAB313026 unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (AA 1-110) antibodyCNR1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1F9 unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (AA 1-110) antibodyCNR1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2F9 unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (N-Term) antibodyCNR1 适用: 人, 大鼠, 小鼠 WB, ELISA, IHC, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (AA 84-99), (Extracellular) antibodyCNR1 适用: 大鼠 WB, IHC, IF, FACS, IC, LCI 宿主: 兔 Polyclonal unconjugated
anti-Cannabinoid Receptor 1 (CNR1) (AA 1-117) antibodyCNR1 适用: 大鼠 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
: "Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain." in: Journal of clinical psychopharmacology, Vol. 30, Issue 4, pp. 441-5, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Expression of cannabinoid receptors in human kidney." in: Histology and histopathology, Vol. 25, Issue 9, pp. 1133-8, (2010) (PubMed).
-
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
-
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
别名
- CB1
-
背景
- This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq].
-
分子量
- 52858
-
NCBI登录号
- NP_001153698, NP_001153730, NP_001153731, NP_057167, NP_149421
-
UniProt
- P21554
-
途径
- Feeding Behaviour
抗原
-
